LifeArc announces £5 million drug repurposing programme for motor neuron disease
Filter by:
  • All
  • News Releases
  • Articles & blogs
  • Ventures Funding
    • 1 June 2017

    XNA polymerases

    What the technology does Polymerases capable of processing unnatural, xeno-nucleic acid (XNA) : alternative genetic polymers not…